Revlimid and Rashes - a phase IV clinical study of FDA data
Rashes is found among people who take Revlimid, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Revlimid and have Rashes. It is created by eHealthMe based on reports of 331,128 people who have side effects when taking Revlimid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
331,128 people reported to have side effects when taking Revlimid.
Among them, 15,559 people (4.7%) have Rashes.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 331,430 Revlimid users for its effectiveness, alternative drugs and more.
What is Rashes?
Rashes (redness) is found to be associated with 5,188 drugs and 6,075 conditions by eHealthMe.
Number of Revlimid and Rashes reports submitted per year:
Time on Revlimid when people have Rashes *:
Gender of people who have Rashes when taking Revlimid*:
Age of people who have Rashes when taking Revlimid *:
Common drugs people take besides Revlimid *:
Common side effects people have besides Rashes *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Revlimid and have Rashes?Check whether Rashes is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Rashes and when was it recovered:
Expand to all the drugs that have ingredients of lenalidomide:
- Rashes and drugs with ingredients of lenalidomide (16,369 reports)
Alternative drugs to, pros and cons of Revlimid:
- Revlimid (331,430 reports)
Common Revlimid side effects:
- Diarrhea: 27,180 reports
- Death: 24,344 reports
- Fatigue (feeling of tiredness): 21,089 reports
- Multiple myeloma (cancer of the plasma cells): 17,070 reports
- Pneumonia: 16,950 reports
- Rashes (redness): 15,559 reports
- Thrombocytopenia (decrease of platelets in blood): 14,033 reports
Browse all side effects of Revlimid:a b c d e f g h i j k l m n o p q r s t u v w x y z
Rashes treatments and more:
- Rashes (603,882 reports)
COVID vaccines that are related to Rashes:
- Rashes in Moderna COVID Vaccine
- Rashes in Pfizer BioNTech Covid Vaccine
- Rashes in Johnson and Johnson Covid Vaccine
Common drugs associated with Rashes:
- Adapalene: 49,040 reports
- Humira: 32,791 reports
- Prednisone: 31,608 reports
- Methotrexate: 30,738 reports
- Enbrel: 29,304 reports
- Green tea: 21,666 reports
- Aspirin: 20,315 reports
- Revlimid: 15,559 reports
- Dupixent: 14,713 reports
- Orencia: 13,951 reports
All the drugs that are associated with Rashes:
- Rashes (5,188 drugs)
Common conditions associated with Rashes:
- Rheumatoid arthritis: 43,808 reports
- Acne: 29,888 reports
- High blood pressure: 18,830 reports
- Multiple myeloma: 18,359 reports
- Multiple sclerosis: 17,182 reports
All the conditions that are associated with Rashes:
- Rashes (6,075 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Qvar Redihaler and Dupuytren'S Contracture - 9 seconds ago
- Adderall 10 and Gastroesophageal Reflux Disease - 11 seconds ago
- Zopiclone vs. Promethazine - 13 seconds ago
- Melatonin and Atrovent Hfa drug interaction - 23 seconds ago
- Promethazine and Sinus Headache - 24 seconds ago
- Brimonidine Tartrate and Methylprednisolone Acetate drug interaction - 24 seconds ago
- Tepezza and Nausea - 28 seconds ago
- Omega 6 and Allopurinol drug interaction - 36 seconds ago
- Zelboraf and Risperdal drug interaction - 39 seconds ago
- Ketoconazole and Haloperidol Lactate drug interaction - 52 seconds ago